Everolimus

NDC 70377-112 · Biocon Pharma Inc.

Generic nameeverolimus

Dosage formTABLET

RouteORAL

Active ingredient(s)EVEROLIMUS

Strength1 mg/1

Pharmacologic classCytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]

Marketing categoryANDA

Packages

70377-112-11 — 60 TABLET in 1 BOTTLE (70377-112-11)

70377-112-21 — 6 BLISTER PACK in 1 CARTON (70377-112-21) / 10 TABLET in 1 BLISTER PACK

Billed under HCPCS

J7527 — Everolimus, oral, 0.25 mg Medicare Part B payment limit (ASP + 6%): $1.16

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70377-010 — everolimus, 70377-011 — everolimus, 70377-012 — everolimus, 70377-013 — everolimus, 70377-069 — Everolimus, 70377-070 — EVEROLIMUS, 70377-071 — everolimus, 70377-090 — Everolimus, 70377-091 — Everolimus, 70377-092 — Everolimus, 72603-254 — everolimus, 72603-255 — everolimus, 72603-256 — everolimus, 72603-257 — everolimus, 82249-610 — Everolimus, 82249-611 — Everolimus, 82249-612 — Everolimus, 82249-613 — Everolimus, 82293-030 — everolimus, 82293-031 — everolimus, +63 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.